DK0593348T3 - Thiazolidin-2,4-dion-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem - Google Patents
Thiazolidin-2,4-dion-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende demInfo
- Publication number
- DK0593348T3 DK0593348T3 DK93402497T DK93402497T DK0593348T3 DK 0593348 T3 DK0593348 T3 DK 0593348T3 DK 93402497 T DK93402497 T DK 93402497T DK 93402497 T DK93402497 T DK 93402497T DK 0593348 T3 DK0593348 T3 DK 0593348T3
- Authority
- DK
- Denmark
- Prior art keywords
- thiazolidine
- preparation
- pharmaceutical compositions
- compositions containing
- dione derivatives
- Prior art date
Links
- 150000001473 2,4-thiazolidinediones Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 230000002310 insulinopenic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000001467 thiazolidinediones Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9212123A FR2696743B1 (fr) | 1992-10-12 | 1992-10-12 | Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0593348T3 true DK0593348T3 (da) | 1999-01-11 |
Family
ID=9434401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93402497T DK0593348T3 (da) | 1992-10-12 | 1993-10-11 | Thiazolidin-2,4-dion-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0593348B1 (da) |
| JP (1) | JP2948076B2 (da) |
| AT (1) | ATE164374T1 (da) |
| AU (1) | AU662658B2 (da) |
| CA (1) | CA2108064C (da) |
| DE (1) | DE69317621T2 (da) |
| DK (1) | DK0593348T3 (da) |
| ES (1) | ES2117114T3 (da) |
| FR (1) | FR2696743B1 (da) |
| GR (1) | GR3026633T3 (da) |
| NZ (1) | NZ248905A (da) |
| ZA (1) | ZA937552B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996012719A1 (en) * | 1994-10-20 | 1996-05-02 | Nippon Chemiphar Co., Ltd. | Quinoline derivative |
| JP3906935B2 (ja) * | 1995-12-18 | 2007-04-18 | 杏林製薬株式会社 | Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| US6121288A (en) * | 1996-11-08 | 2000-09-19 | Nippon Chemiphar Co., Ltd. | Visceral fat lowering agent |
| AU7595298A (en) * | 1997-12-02 | 1998-12-11 | Dr. Reddy's Research Foundation | Azolidinediones useful for the treatment of diabetes, dyslipidemia and hy pertension |
| IN187716B (da) * | 1998-09-14 | 2002-06-15 | Reddy Research Foundation | |
| PL2220030T3 (pl) * | 2007-11-06 | 2016-07-29 | Bioelectron Tech Corp | Pochodne 4-(p-chinonylo)-2-hydroksybutanamidu do leczenia chorób mitochondrialnych |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| DK173350B1 (da) * | 1985-02-26 | 2000-08-07 | Sankyo Co | Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem |
| FI904414A7 (fi) * | 1988-03-08 | 1990-09-07 | Pfizer | Tiatsolidiinidioni-hypoglykeemisesti vaikuttavat aineet |
| WO1989008652A1 (en) * | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Thiazolidinedione derivatives as hypoglycemic agents |
| WO1989008651A1 (en) * | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
| GB8919434D0 (en) * | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
| US5143930A (en) * | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
| GB9023584D0 (en) * | 1990-10-30 | 1990-12-12 | Beecham Group Plc | Novel compounds |
-
1992
- 1992-10-12 FR FR9212123A patent/FR2696743B1/fr not_active Expired - Fee Related
-
1993
- 1993-10-08 CA CA002108064A patent/CA2108064C/fr not_active Expired - Fee Related
- 1993-10-11 DK DK93402497T patent/DK0593348T3/da active
- 1993-10-11 ES ES93402497T patent/ES2117114T3/es not_active Expired - Lifetime
- 1993-10-11 EP EP93402497A patent/EP0593348B1/fr not_active Expired - Lifetime
- 1993-10-11 AT AT93402497T patent/ATE164374T1/de not_active IP Right Cessation
- 1993-10-11 NZ NZ248905A patent/NZ248905A/en unknown
- 1993-10-11 DE DE69317621T patent/DE69317621T2/de not_active Expired - Fee Related
- 1993-10-11 AU AU48905/93A patent/AU662658B2/en not_active Ceased
- 1993-10-12 ZA ZA937552A patent/ZA937552B/xx unknown
- 1993-10-12 JP JP5287220A patent/JP2948076B2/ja not_active Expired - Lifetime
-
1998
- 1998-04-14 GR GR980400832T patent/GR3026633T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ248905A (en) | 1994-12-22 |
| EP0593348B1 (fr) | 1998-03-25 |
| DE69317621D1 (de) | 1998-04-30 |
| ES2117114T3 (es) | 1998-08-01 |
| CA2108064A1 (fr) | 1994-04-13 |
| ATE164374T1 (de) | 1998-04-15 |
| FR2696743B1 (fr) | 1994-12-23 |
| DE69317621T2 (de) | 1998-10-15 |
| CA2108064C (fr) | 2001-10-23 |
| AU4890593A (en) | 1994-04-28 |
| GR3026633T3 (en) | 1998-07-31 |
| JP2948076B2 (ja) | 1999-09-13 |
| ZA937552B (en) | 1994-05-02 |
| FR2696743A1 (fr) | 1994-04-15 |
| EP0593348A1 (fr) | 1994-04-20 |
| JPH07309852A (ja) | 1995-11-28 |
| AU662658B2 (en) | 1995-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU560179B2 (en) | Hypoglycemic thiazolidinedione derivatives | |
| DE3071202D1 (en) | Thiazolidine compounds, processes for their preparation and pharmaceutical compositions containing them | |
| ATE144503T1 (de) | Thiazolidin-2,4-dionderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| LU90014I2 (fr) | Invirase ou un de ses dérivés ou sels pharmaceutiquement acceptables Saquinavir | |
| DK65193D0 (da) | 4,5-dihydro-2-(substitueret phenyl)-1,2,4-triazin-3,5(3h)-dionforbindelser, fremgangsmaade til fremstilling deraf samt praeparater indeholdende disse forbindelser | |
| NO940506D0 (no) | Heterocykliske, substituerte fenyl-cykloheksan-karboksylsyrederivater | |
| GB9211172D0 (en) | Compounds | |
| NO20052683L (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| CA2321188A1 (en) | Derivatives of azetidine and pyrrolidine | |
| ES2132135T3 (es) | Procedimiento para la preparacion de compuestos de tiazolidina u oxazolidina farmaceuticamente activos mediante una reductasa de levadura. | |
| HU9203284D0 (en) | Method for producing thiazolidine-2,4-dione derivatives and medical preparatives containing these compounds | |
| MX9201736A (es) | Derivados de aminoacido y procedimiento para su preparacion. | |
| GR3026633T3 (en) | Thiazolidine dione derivatives, process for their preparation and pharmaceutical compositions containing them. | |
| HU199684B (en) | Process for producing pharmaceutical compositions containing 2-pyrimidinyl-1-piperazin derivatives against alcoholism | |
| NO940274D0 (no) | 2-(4-(-azolbutyl)-1-piperazinyl)-5-hydroksy-pyrimidinderivater, deres fremstilling og anvendelse som legemidler | |
| DK0632026T3 (da) | Alfa-aminosyrederivater, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem | |
| DK520787A (da) | Terapeutisk middel indeholdende propentofyllin eller derivater deraf til brug ved behandling af peptisk ulcus | |
| DK423289D0 (da) | Sulfonamider med tetrazolylrest, fremgangsmaade til deres fremstilling samt laegemiddel | |
| IL70690A (en) | 5-(2-alkoxyphenyl)thiazolidinediones and pharmaceutical compositions containing them | |
| NZ524933A (en) | Sodium salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical composition thereof | |
| ATE66232T1 (de) | Pyrimido(5,4-b>(1,4>oxazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie zwischenprodukte darstellende pyrimido(5,4-b>(1,4>oxazinderivate. | |
| DE69400283D1 (de) | (Cyclohexyl)alkenderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| AP1841A (en) | A thiazolidinedione derivative and its use as antidiabetic. | |
| NO20030531L (no) | Tartratsalter av tiazolidindionderivater |